Literature DB >> 32331597

Syndecan-4: major player or innocent bystander of the endothelial glycocalyx?

Kevin J McCarthy1.   

Abstract

Glycocalyces are the pericellular coat of glycoproteins, glycolipids, and proteoglycans. Yet the exploration of glycocalyx function is still ongoing because of the availability of investigative tools capable of discerning the function of one component without inflicting collateral changes in the organization/function of other constituents. The current report by Ramnath et al. explores the function of one family of molecules, the syndecans, as potential regulators of endothelial cell glycocalyx thickness in normal and diabetic glomeruli.
Copyright © 2020 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32331597      PMCID: PMC8092442          DOI: 10.1016/j.kint.2020.01.040

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  10 in total

Review 1.  Proteoglycans in health and disease: the multiple roles of syndecan shedding.

Authors:  Tina Manon-Jensen; Yoshifumi Itoh; John R Couchman
Journal:  FEBS J       Date:  2010-08-31       Impact factor: 5.542

Review 2.  Role of the endothelial surface layer in neutrophil recruitment.

Authors:  Alex Marki; Jeffrey D Esko; Axel R Pries; Klaus Ley
Journal:  J Leukoc Biol       Date:  2015-05-15       Impact factor: 4.962

Review 3.  Structures and interactions of syndecans.

Authors:  Frank Gondelaud; Sylvie Ricard-Blum
Journal:  FEBS J       Date:  2019-04-08       Impact factor: 5.542

4.  Endothelial surface glycocalyx (ESG) components and ultra-structure revealed by stochastic optical reconstruction microscopy (STORM).

Authors:  Jie Fan; Yi Sun; Yifan Xia; John M Tarbell; Bingmei M Fu
Journal:  Biorheology       Date:  2019       Impact factor: 1.875

5.  The proteoglycan syndecan 4 regulates transient receptor potential canonical 6 channels via RhoA/Rho-associated protein kinase signaling.

Authors:  Ying Liu; Frank Echtermeyer; Florian Thilo; Gregor Theilmeier; Antje Schmidt; Ralf Schülein; Boye L Jensen; Christoph Loddenkemper; Vera Jankowski; Niels Marcussen; Maik Gollasch; William J Arendshorst; Martin Tepel
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-12-08       Impact factor: 8.311

6.  Glomerular Function and Structural Integrity Depend on Hyaluronan Synthesis by Glomerular Endothelium.

Authors:  Bernard M van den Berg; Gangqi Wang; Margien G S Boels; M Cristina Avramut; Erik Jansen; Wendy M P J Sol; Franck Lebrin; Anton Jan van Zonneveld; Eelco J P de Koning; Hans Vink; Hermann-Josef Gröne; Peter Carmeliet; Johan van der Vlag; Ton J Rabelink
Journal:  J Am Soc Nephrol       Date:  2019-07-15       Impact factor: 10.121

7.  Mapping of matrix metalloproteinase cleavage sites on syndecan-1 and syndecan-4 ectodomains.

Authors:  Tina Manon-Jensen; Hinke A B Multhaupt; John R Couchman
Journal:  FEBS J       Date:  2013-03-04       Impact factor: 5.542

Review 8.  Heparan sulfate proteoglycan as a cell-surface endocytosis receptor.

Authors:  Helena C Christianson; Mattias Belting
Journal:  Matrix Biol       Date:  2013-10-18       Impact factor: 11.583

9.  Blocking matrix metalloproteinase-mediated syndecan-4 shedding restores the endothelial glycocalyx and glomerular filtration barrier function in early diabetic kidney disease.

Authors:  Raina D Ramnath; Matthew J Butler; Georgina Newman; Sara Desideri; Amy Russell; Abigail C Lay; Chris R Neal; Yan Qiu; Sarah Fawaz; Karen L Onions; Monica Gamez; Michael Crompton; Chris Michie; Natalie Finch; Richard J Coward; Gavin I Welsh; Rebecca R Foster; Simon C Satchell
Journal:  Kidney Int       Date:  2019-11-02       Impact factor: 10.612

Review 10.  The Role of Heparanase and Sulfatases in the Modification of Heparan Sulfate Proteoglycans within the Tumor Microenvironment and Opportunities for Novel Cancer Therapeutics.

Authors:  Edward Hammond; Ashwani Khurana; Viji Shridhar; Keith Dredge
Journal:  Front Oncol       Date:  2014-07-24       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.